Dr Reddy's Laboratories Total Long-Term Assets 2010-2024 | RDY

Dr Reddy's Laboratories total long-term assets for the quarter ending June 30, 2024 were $1.754B, a 15.32% increase year-over-year.

  • Dr Reddy's Laboratories total long-term assets for 2024 were $1.674B, a 19.66% increase from 2023.
  • Dr Reddy's Laboratories total long-term assets for 2023 were $1.399B, a 4.31% decline from 2022.
  • Dr Reddy's Laboratories total long-term assets for 2022 were $1.462B, a 8.74% decline from 2021.

Dr Reddy's Laboratories Total Long-Term Assets 2010-2024 | RDY

  • Dr Reddy's Laboratories total long-term assets for 2024 were $1.674B, a 19.66% increase from 2023.
  • Dr Reddy's Laboratories total long-term assets for 2023 were $1.399B, a 4.31% decline from 2022.
  • Dr Reddy's Laboratories total long-term assets for 2022 were $1.462B, a 8.74% decline from 2021.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$20.1B
BridgeBio Pharma (BBIO)$5B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.4B
Supernus Pharmaceuticals (SUPN)$1.8B
Taysha Gene Therapies (TSHA)$449M
Personalis (PSNL)$315M
Assembly Biosciences (ASMB)$117M
Acasti Pharma (ACST)$28M
Sol-Gel Technologies (SLGL)$20M
Evoke Pharma (EVOK)$4M
Teligent (TLGT)$0M